Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 98.1% | 117.6% | 232.5% | 97.8% | 127.9% | 107.7% | 166.9% | 158.2% | 126.1% | 84.6% | 113.7% | 117.2% | 151.4% | 929.8% | 207.2% | 122.0% | 127.3% | 122.3% | 112.6% | 88.4% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 112.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Abbott Laboratories have been 109.8% over the past three years, and 121.0% over the past five years.
As of today, Abbott Laboratories's FCF to Net Income is 112.9%, which is higher than industry median of 78.8%. It indicates that Abbott Laboratories's FCF to Net Income is Good.